Completeness Stats

Per-lemma coverage of translations, IPA, audio, and synonym groups. ← Back to summary

Clear
Matching rows: 7816
Lemma POS Level Trans (all) Tier 1 Tier 2 Tier 3 IPA Audio Relations Sentences
esomeprazole
N16_520 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
famotidine
N16_521 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
sucralfate
N16_522 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
dicyclomine
N16_523 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
bisacodyl
N16_524 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
bismuth subsalicylate
N16_525 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
promethazine
N16_526 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
prochlorperazine
N16_527 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
meclizine
N16_528 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
dimenhydrinate
N16_529 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
tamsulosin
N16_530 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
finasteride
N16_531 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
oxybutynin
N16_532 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
sildenafil
N16_533 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
tadalafil
N16_534 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
clobetasol
N16_535 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
valacyclovir
N16_536 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
prednisone
N16_537 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
etanercept
N16_538 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
infliximab
N16_539 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
certolizumab
N16_540 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
golimumab
N16_541 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
abatacept
N16_542 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
tocilizumab
N16_543 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
secukinumab
N16_544 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
ixekizumab
N16_545 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
guselkumab
N16_546 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
risankizumab
N16_547 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
upadacitinib
N16_548 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
tofacitinib
N16_549 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
apremilast
N16_550 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
dupilumab
N16_551 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
omalizumab
N16_552 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
mepolizumab
N16_553 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
benralizumab
N16_554 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
tezepelumab
N16_555 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
vedolizumab
N16_556 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
ocrelizumab
N16_557 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
natalizumab
N16_558 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
fingolimod
N16_559 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
ozanimod
N16_560 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
eculizumab
N16_561 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
ravulizumab
N16_562 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
nivolumab
N16_563 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
atezolizumab
N16_564 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
durvalumab
N16_565 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
pertuzumab
N16_566 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
daratumumab
N16_567 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
osimertinib
N16_568 		noun 1150 6 4/4 0/5 0/13 0 0 0 0
palbociclib
N16_569 		noun 1150 6 4/4 0/5 0/13 0 0 0 0